Wounding the stroma: Docetaxel's role in dormant breast cancer escape
- PMID: 37703292
- PMCID: PMC10499231
- DOI: 10.1371/journal.pbio.3002297
Wounding the stroma: Docetaxel's role in dormant breast cancer escape
Abstract
The mechanistic underpinnings of breast cancer recurrence following periods of dormancy are largely undetermined. A new study in PLOS Biology reveals that docetaxel-induced injury of tumour stromal cells stimulates the release of cytokines that support dormancy escape of breast cancer cells.
Copyright: © 2023 Cooper, Postovit. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Comment on
-
Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape.PLoS Biol. 2023 Sep 12;21(9):e3002275. doi: 10.1371/journal.pbio.3002275. eCollection 2023 Sep. PLoS Biol. 2023. PMID: 37699010 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical